Literature DB >> 28520534

CpG Island Methylation Correlates with the Use of Alternative Promoters for USP44 Gene Expression in Human Pluripotent Stem Cells and Testes.

Philippe Tropel1, Laura Jung1, Cécile André1, Adeline Ndandougou1, Stéphane Viville1.   

Abstract

Deubiquitinating enzymes may play a major regulatory role in pluripotent stem cells (PSCs), but few studies have investigated this topic. Within this family of enzymes, we found that the ubiquitin-specific peptidase USP44, is highly expressed in embryonic stem cells, induced PSCs (iPSCs), and testes as compared with differentiated progenies and somatic organs. Analysis by quantitative polymerase chain reaction and 5' RACE showed that alternate promoters are responsible for expression in PSCs and organs. We noticed seven regions of transcription initiation, some of them with cell- or tissue-specific activity. Close analysis showed that one of the promoters involved in stem cell- and testis-specific activity is differentially regulated in those tissues. At the epigenetic level, USP44 transcription was correlated with DNA methylation of a CpG island close to the main promoter region. These data imply a complex picture where regulating factors such as OCT4 may interact with other epigenetic mechanisms to regulate USP44 expression in PSCs and testes.

Entities:  

Keywords:  DNA methylation; USP44; pluripotent stem cells; promoter; regulation; transcription initiation start

Mesh:

Substances:

Year:  2017        PMID: 28520534     DOI: 10.1089/scd.2017.0057

Source DB:  PubMed          Journal:  Stem Cells Dev        ISSN: 1547-3287            Impact factor:   3.272


  2 in total

1.  Highly Sensitive Detection of Human Pluripotent Stem Cells by Loop-Mediated Isothermal Amplification.

Authors:  Ryota Yasui; Atsuka Matsui; Keisuke Sekine; Satoshi Okamoto; Hideki Taniguchi
Journal:  Stem Cell Rev Rep       Date:  2022-06-03       Impact factor: 5.739

2.  Orphan CpG islands as alternative promoters.

Authors:  Shrutii Sarda; Sridhar Hannenhalli
Journal:  Transcription       Date:  2017-11-28
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.